Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Healing, Recovery & Immune · Washington, DC
TB-500 is documented by ReVia for tissue-repair and regenerative research labs across Washington, DC, including teams in Bethesda, Arlington, and Alexandria. A synthetic fragment of Thymosin Beta-4, TB-500 is investigated for systemic tissue-repair pathways, inflammation modulation, and wound-healing models. Every vial is shipped research-use-only and supported by third-party COA testing reflecting the capital region's high standards.
A synthetic peptide representing the active region of thymosin beta-4 (TB4). Studies have investigated its effects on actin regulation, cell migration, angiogenesis, and tissue repair mechanisms across multiple tissue types.
TB-500 belongs to the actin-binding peptide class as a synthetic Thymosin Beta-4 sequence studied across the capital region's science-forward market. Research groups in Washington, Arlington, Alexandria, and Bethesda characterize its preclinical influence on cell migration, actin-filament dynamics, and tissue-repair cell models, keeping every observation inside controlled, in-vitro, research-use-only conditions.
TB-500 is worked with by researchers throughout the Washington metro — including Arlington, Alexandria, Bethesda, Silver Spring — and across East Coast. The capital region's science-forward market. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Washington, DC laboratories obtain TB-500?
TB-500 is supplied through i2b Health, ReVia's research partner, to researchers in qualified research facilities in Washington, DC and the surrounding Bethesda and Alexandria areas. All supply is for laboratory and research use only.
Is TB-500 third-party tested?
TB-500 is analyzed by independent laboratories and accompanied by a Certificate of Analysis verifying identity and purity. DC-area researchers can request the COA with any order.
What is TB-500 studied for?
TB-500, a synthetic Thymosin Beta-4 fragment, is researched for systemic tissue repair, reduced inflammation, and accelerated wound-healing in laboratory models. It is intended exclusively for research use.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.